| _creationDate | October 21, 2020 |
| _modificationDate | December 9, 2024 |
| _creator | Vn048 |
| _fullText | {{ServiceRequestCase
|identifier=DZI20-210-Case-1
|intent=order
|category=409073007
|priority=routine
|orderDetail=case
|locationCode=learn
|basedOn=DZI20-210
|code=faculty
|supportingInfo=SKIN: LEFT upper back and arm: CD8+ cutaneous T cell lymphoma.
IHC: Aypical lymphocytes are CD3+ CD7+ CD5+ (su ... |
| _numRevisions | 6 |
| _isRedirect | No |
| identifier | DZI20-210-Case-1 |
| basedOn | DZI20-210 |
| requisition | null |
| intent | order |
| category | 409073007 |
| priority | routine |
| code | faculty |
| orderDetail | case |
| subject | MGH |
| occurrenceDateTime | December 31, 1969 7:00:00 PM |
| authoredOn | October 21, 2020 2:16:00 PM |
| requester | Vn048 |
| performer | VN048 |
| locationCode | learn |
| reasonCode | 70 yo with 3 week history of hemorrhagic tumors |
| supportingInfo | SKIN: LEFT upper back and arm: CD8+ cutaneous T cell lymphoma.
IHC: Aypical lymphocytes are CD3+ CD7+ CD5+ (subset) • CD8+ • TIA+ • Perforin+ • Granzyme+ • and negative for CD2 • CD56 • CD4 • CD30. CD25 shows weak reactivity in ~40-50% of cells. Mib1 is approximately 90%. |
| specimen | null |
| bodySite | null |
| sequence | 1 |
| access | public |
| identifier | DZI20-210-Case-1_1 |
| basedOn | DZI20-210-Case-1 |
| partOf | DZI20-210 |
| status | completed |
| type | image |
| modality | mrxs |
| view | show |
| createdDateTime | October 21, 2020 2:16:00 PM |
| operator | Vn048 |
| reasonCode | H&E |
| bodySite | null |
| frames | 1 |
| content | DZI20-210-Case-1_1.mrxs |
| note | null |
| subject | Z0FBQUFBQmZrRVV6NGxsTGZmc1FyOUpBRzhIbkNIdHZDbVhwN1ZWQnNFMnE4ZmFWTHQ0TDliLXZsU0Q0U2hyWjA4LWl2RTJSN1NhZnFaSWZpaF9VT09rWGtIamlYVW85aWc9PQ |
| status | active |
| identifier | DZI20-210-Case-1 |
| requester | Vn048 |
| authoredOn | October 21, 2020 2:16:00 PM |
